"Great news from Pfizer & BioNTech Group on the successful results of the latest clinical trial for COVID19 vaccine," European Commission President Ursula von der Leyen wrote in a Twitter post, adding that "European science works!" .
She announced that "the European Commission will soon sign a contract for up to 300 million doses of the vaccine".
Global optimism was sparked by Pfizer Inc.'s announcement that its experimental vaccine is 90% and more effective in protecting against COVID-19 based on its test findings.
Pfizer plans to apply for a broad license for emergency use of the vaccine for ages 16 to 85 at the end of November but can not yet apply for an emergency permit from the US Food and Drug Administration (FDA) because the merger has not been completed. security data, stressed yesterday the president of the company Alberto Bourla. He noted that enough data will have been collected, as required by the organization, in the third week of November. The data contained in the application for approval of the vaccine will be evaluated not only by the scientists of the organization, but also by an external panel of independent experts in a public assembly, Mr. Bourla said in October.
Although the study has not yet been completed, so the results have not been sent to approval agencies, the two companies are expected to have produced up to 50 million doses of the vaccine by the end of the year and up to 1,3 billion doses by 2021.
The Pfizer & BioNTech Group vaccine against Covid-19 disease, which may be released by March 2021 for the most vulnerable populations, could, along with other advances, fundamentally change the course of the pandemic, a senior UN official has said. Health.
Bruce Ellward also told the WHO's annual general meeting that the provisional results announced by Pfizer Inc. on the final stages of a vaccine were "very positive".
"There is still a lot of work to be done, it is a temporary result; but it is a very positive result that was announced today, which is expected to be very promising, to give a lot of hope, to the whole world, as we move forward," he said. Eilward, before the 194 members of the WHO.
For his part, the director general of the World Health Organization, Tentros, Antanom Gebregesus, called "encouraging" the announcement made today by Pfizer and BioNTech labs about a "90% effective" vaccine against Covid-19.
"We welcome the encouraging news about the vaccine from @pfizer and @BioNTech_Group and welcome all the scientists and partners around the world who are developing new tools, useful and effective, to beat Covid-19," the tweet read. written by the head of the WHO.
"People know of an unprecedented innovation and scientific collaboration to put an end to the pandemic," he added.
According to the Wall Street Journal, the vaccine was developed by Pfizer Inc. and BioNTech SE proved better than expected for protecting humans against coronavirus in Covid-19 in a central study. This development is a milestone in the vaccine race that can stop the global pandemic. The vaccine has been shown to be more than 90% effective in the first 94 people who became infected with the new coronavirus and developed at least one symptom.
What Pfizer analysis showed
The assay evaluated 94 confirmed Covid-19 infections among the 43.538 participants in the trial. Pfizer and BioNTech reported that analyzing the results in the two groups of people who took the test - those who received the vaccine and those who received placebo - showed an efficacy rate of more than 90% seven days after the second dose.
This means that protection against Covid-19 is achieved 28 days after the initial vaccination, which consists of a two-dose program. The final efficacy rate of the vaccine may vary, however, as safety and additional data continue to be collected.
How scientists received the news
Anthony Fauci described the results of the vaccine as "great news", who, speaking to CNN, did not rule out the release of the vaccine on the market by the end of the year.